SPP1 and UMOD gene variants are synergistically associated with risk of renal stone disease
Gene · 2023
DOI: 10.1016/j.gene.2023.147264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene, 2023. Verfasst von Yash P Patel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, I…. Hauptthemen laut MEDLINE: Kidney Calculi, Hyperoxaluria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Charotar University of Science and Technology.
Abstract (Originalsprache)
OBJECTIVE: Calcium and oxalate are the most abundant metabolites present in the stone matrix. The SPP1 and UMOD gene has specific expression in kidneys and are involved in various stages of stone formation. Therefore, genetic variants in the SPP1 and UMOD genes may enhance the development of renal stone disease. This study has been designed to understand the association of genetic variants of SPP1 and UMOD genes with renal stone disease. MATERIALS AND METHOD: A prospective study has been carried out, including 150 renal stone disease patients and 150 healthy individuals. Biochemical parameters were performed, including serum calcium levels, creatinine, parathyroid hormone, and 24-Hour urine metabolites. The genotyping of SPP1 (rs1126616) and UMOD (rs4293393) gene variants were performed using a customized TaqMan probe. T-test was used for continuous biochemical data analysis. The Chi-square test has been applied to assess the risk of a particular genotype associated with renal stone disease. In addition, correlation analysis for biochemical parameters and genetic variants with the renal stone disease has been performed using Shapley additive explanations (SHAP) values calculated with the help of the pycaret library. RESULT: Renal stone patients had significantly higher levels of parathyroid hormone (93.37 ± 52.78 pg/ml vs 64.67 ± 31.50 pg/ml, P=
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, India.
- Department of Pharmaceutical Chemistry and Analysis, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, India.
- Department of Pharmacology, L.M. College of Pharmacy, Ahmedabad, Gujarat 380009, India.
- Department of Urology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat 387001, India.
- Department of Pathology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat 387001, India.
- School of Life Sciences, Department of Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, UP 226025, India.
Förderung
- Charotar University of Science and Technology
Zitieren
APA
Patel, Y. P., Patel, S. G., Patel, S. B., Parikh, A., Soni, S., Srivastava, R., Raval, C., Raval, M. A., Nand Pandey, S., Ganpule, A. P., & Desai, M. R. (2023). SPP1 and UMOD gene variants are synergistically associated with risk of renal stone disease. Gene. https://doi.org/10.1016/j.gene.2023.147264
Vancouver
Patel YP, Patel SG, Patel SB, Parikh A, Soni S, Srivastava R, et al. SPP1 and UMOD gene variants are synergistically associated with risk of renal stone disease. Gene. 2023. doi:10.1016/j.gene.2023.147264
BibTeX
@article{Patel2023,
author = {Patel, Yash P and Patel, Samir G and Patel, Sandip B and Parikh, Aditya and Soni, Shailesh and Srivastava, Ratika and Raval, Chintal and Raval, Manan A and Nand Pandey, Sachchida and Ganpule, Arvind P and Desai, Mahesh R},
title = {SPP1 and UMOD gene variants are synergistically associated with risk of renal stone disease},
journal = {Gene},
year = {2023},
doi = {10.1016/j.gene.2023.147264}
}
EUVIMED